# Brinzolamide-brimonidine Fixed Combination for Preventing IOP Elevation After Intravitreal Anti-VEGF Injections

> **NCT04523844** · NA · COMPLETED · sponsor: **General Hospital of Athens Elpis** · enrollment: 47 (actual)

## Conditions studied

- Eye Diseases
- Injection Complication
- Intraocular Pressure

## Interventions

- **DRUG:** Brinzolamide-brimonidine Fixed Combination

## Key facts

- **NCT ID:** NCT04523844
- **Lead sponsor:** General Hospital of Athens Elpis
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-11
- **Primary completion:** 2020-07-30
- **Final completion:** 2020-07-30
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2020-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04523844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04523844, "Brinzolamide-brimonidine Fixed Combination for Preventing IOP Elevation After Intravitreal Anti-VEGF Injections". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04523844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*